Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Medicon Valley Developing R&D Capabilities, Attracting Attention

Nov. 20, 2002

By Cormac Sheridan

Medicon Valley, the transnational region spanning the greater Copenhagen area in Denmark and the Sk ne region in southern Sweden, is laying claim to global leadership in diabetes R&D capability. (BioWorld International)

Prokaria Fishing For Products In The Hot Springs Of Iceland

Nov. 20, 2002

By Cormac Sheridan

Medicon Valley Developing R&D Capabilities, Attracting Attention

Nov. 20, 2002

By Cormac Sheridan

Medicon Valley, the transnational region spanning the greater Copenhagen area in Denmark and the Sk ne region in southern Sweden, is laying claim to global leadership in diabetes R&D capability. (BioWorld International)

Medicon Valley Developing R&D Capabilities In Four Key Areas

Nov. 18, 2002

By Cormac Sheridan

Medicon Valley Developing R&D Capabilities In Four Key Areas

Nov. 18, 2002

By Cormac Sheridan

Meridian, Biotrin Call Off Merger Talks, Decline To Provide Details

Nov. 13, 2002

By Cormac Sheridan

Meridian, Biotrin Call Off Merger Talks, Decline To Provide Details

Nov. 13, 2002

By Cormac Sheridan

NeuroSearch, Boehringer Ingelheim Move Alzheimer's Drug To Phase IIb

Nov. 6, 2002

By Cormac Sheridan

Advances In Irish Biotech Efforts On Display At Meeting Next Week

Nov. 6, 2002

By Cormac Sheridan

NeuroSearch, Boehringer Ingelheim Move Alzheimer's Drug To Phase IIb

Nov. 6, 2002

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...